MedTrace Logo

Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease

NCT06239402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 394

Last updated 2025-02-20

No results posted yet for this study

Summary

The study aims to depict the actual prescription patterns employed in clinical practice of patients affected by non-valvular atrial fibrillation undergoing percutaneous coronary intervention (i.e. with a therapeutic indication for dual or triple antithrombotic therapy) and to analyze the outcomes of therapeutic decisions, focusing on mortality, hemorrhagic events, and ischemic events,

Conditions

Interventions

OTHER

Observation

Observation of mortality, haemorrhagic and ischemic events in the studied population

Sponsors & Collaborators

  • Società Italiana Cardiologia Ospedalità Accreditata (SICOA)

    collaborator UNKNOWN

  • Istituti Clinici Scientifici Maugeri SpA

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2024-07-28
Completion
2024-07-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06239402 on ClinicalTrials.gov